---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-012579"
form_type: "8-K"
ticker: "ATOS"
cik: "0001488039"
company_name: "ATOSSA THERAPEUTICS, INC."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T21:39:05.769235+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Atossa Therapeutics reports 2023 annual meeting vote results; all proposals passed

## Summary
- Elected directors: Galli with 15,993,221 for, Steinhart with 22,292,391 for; broker non-votes ~30M.
- Ratified BDO USA as auditor for FY2023: 54,079,294 for, 1,607,433 against, 1,113,613 abstain.
- Advisory vote on executive compensation approved: 21,091,953 for, 4,707,752 against, 910,013 abstain.
- Total shares voted: 56,800,340 out of 126,624,110 entitled shares.

## SEC filing metadata
- accession: 0001437749-23-012579
- form_type: 8-K
- ticker: ATOS
- cik: 0001488039
- company_name: ATOSSA THERAPEUTICS, INC.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488039/000143774923012579/0001437749-23-012579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488039/000143774923012579/atos20230502_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-012579
- JSON: https://secwatch.observer/filing/0001437749-23-012579.json
- Plain text: https://secwatch.observer/filing/0001437749-23-012579.txt

## Key facts
- Shareholder Votes
  ATOSSA THERAPEUTICS, INC. shareholders approved Election of two Class II Directors at the 2023-05-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-04
  source text: The stockholders elected two Class II directors as set forth below: Nominee Votes For Votes Withheld Broker Non-Votes Stephen J. Galli, M.D. 15,993,221 10,716,498 30,090,621 Richard I. Steinhart 22,292,391 4,417,328 30,090,621
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488039/000143774923012579/0001437749-23-012579-index.htm
- Shareholder Votes
  ATOSSA THERAPEUTICS, INC. shareholders approved Ratification of the selection of BDO USA LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-05-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-04
  source text: The stockholders ratified the appointment of BDO USA LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 as set forth below: Votes For Votes Against Abstain Broker Non-Votes 54,079,294 1,607,433 1,113,613 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488039/000143774923012579/0001437749-23-012579-index.htm
- Shareholder Votes
  ATOSSA THERAPEUTICS, INC. shareholders approved Advisory vote to approve executive compensation at the 2023-05-04 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-05-04
  source text: The stockholders approved an advisory non-binding vote on executive compensation as follows: Votes For Votes Against Abstain Broker Non-Votes 21,091,953 4,707,752 910,013 30,090,622
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488039/000143774923012579/0001437749-23-012579-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.